← All trials
NCT03337451
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 27, 2018
- Primary completion
- Jul 31, 2019
- Completion date
- Jul 31, 2019
- First posted
- —
- Last posted
- —
- Enrollment
- 57
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Opsona Therapeutics Ltd.Lead sponsor
- University of Texas at HoustonCollaborator
- Yeshiva UniversityCollaborator
- University of South FloridaCollaborator
- New York Presbyterian HospitalCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.